Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biotechnology Companies in 2024
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.
  1. Pharvaris N.V.

    World Rank (Jan-05-2024)
    7,301
    Market Cap (Jan-05-2024)
    1.326 Billion USD
    World Rank (Jul-30-2023)
    11,900
    Market Cap (Jul-30-2023)
    0.573 Billion USD
    World Rank (Dec-25-2022)
    15,021
    Market Cap (Dec-25-2022)
    0.335 Billion USD
    World Rank (Jan-07-2022)
    11,928
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Headquarters Country
    Company Profile
    Pharvaris is a biotechnology sector company related clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Headquarters is in Netherlands.
  2. BioCryst Pharmaceuticals

    World Rank (Jan-05-2024)
    7,310
    Market Cap (Jan-05-2024)
    1.323 Billion USD
    World Rank (Jul-30-2023)
    7,021
    Market Cap (Jul-30-2023)
    1.451 Billion USD
    World Rank (Dec-25-2022)
    5,228
    Market Cap (Dec-25-2022)
    2.135 Billion USD
    World Rank (Jan-07-2022)
    6,134
    Market Cap (Jan-07-2022)
    2.08 Billion USD
    Annual Revenue in USD
    270 Million USD
    Annual Operating Income in USD
    -148 Million USD
    Annual Net Income in USD
    -247 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    BioCryst Pharmaceuticals is a Biotechnology company designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). The company annual revenue is 49 million USD and 140 employees as on 2019. The headquarters is in USA.
  3. Protagonist Therapeutics

    World Rank (Jan-05-2024)
    7,332
    Market Cap (Jan-05-2024)
    1.316 Billion USD
    World Rank (Jul-30-2023)
    8,303
    Market Cap (Jul-30-2023)
    1.093 Billion USD
    World Rank (Dec-25-2022)
    12,464
    Market Cap (Dec-25-2022)
    0.496 Billion USD
    World Rank (Jan-07-2022)
    7,030
    Market Cap (Jan-07-2022)
    1.66 Billion USD
    Annual Revenue in USD
    27 Million USD
    Annual Operating Income in USD
    -131 Million USD
    Annual Net Income in USD
    -127 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Protagonist Therapeutics is a Clinical Stage Biopharmaceutical company with multiple peptide based new chemical entities in different stages of development. The headquarters is in USA.

    Facts About Company

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2022 was 26 million USD and and Net loss for year ending Dec-2022 was -127 million USD.

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -125 million USD.

    As on 2022, Protagonist Therapeutics has 105 employees.

  4. Sage Therapeutics

    World Rank (Jan-05-2024)
    7,382
    Market Cap (Jan-05-2024)
    1.301 Billion USD
    World Rank (Jul-30-2023)
    5,572
    Market Cap (Jul-30-2023)
    2.089 Billion USD
    World Rank (Dec-25-2022)
    4,977
    Market Cap (Dec-25-2022)
    2.288 Billion USD
    World Rank (Jan-07-2022)
    5,501
    Market Cap (Jan-07-2022)
    2.48 Billion USD
    Annual Revenue in USD
    8 Million USD
    Annual Operating Income in USD
    -546 Million USD
    Annual Net Income in USD
    -532 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Bio Pharmaceutical company with headquarters is in Massachusetts, USA.
  5. Wuhan Keqian Biology Co. Ltd

    World Rank (Jan-05-2024)
    7,412
    Market Cap (Jan-05-2024)
    1.292 Billion USD
    World Rank (Jul-30-2023)
    6,731
    Market Cap (Jul-30-2023)
    1.551 Billion USD
    World Rank (Dec-25-2022)
    6,653
    Market Cap (Dec-25-2022)
    1.464 Billion USD
    World Rank (Jan-07-2022)
    5,929
    Market Cap (Jan-07-2022)
    2.19 Billion USD
    Headquarters Country
  6. Heska Corporation

    World Rank (Jan-05-2024)
    7,441
    World Rank (Jul-30-2023)
    7,441
    Market Cap (Jul-30-2023)
    1.310 Billion USD
    World Rank (Dec-25-2022)
    10,551
    Market Cap (Dec-25-2022)
    0.674 Billion USD
    World Rank (Jan-07-2022)
    7,154
    Market Cap (Jan-07-2022)
    1.61 Billion USD
    Annual Revenue in USD
    253 Million USD
    Annual Net Income in USD
    -1 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Heska Corporation has innovation, invention and strategic partnerships with worldwide leaders in diagnostics and treatments. It provides the benefits of latest generation technologies to Pet Healthcare Providers company. Heska’s range of complete blood diagnostic solutions include Chemistry, Hematology, Blood Gas & Electrolytes, Immunodiagnostics, Heartworm, and other blood testing. The headquarters is in USA.

    Facts About Company

    The company annual revenue is 45.7 million USD and 347 employees as on 2020.

  7. Deciphera Pharmaceuticals

    World Rank (Jan-05-2024)
    7,448
    Market Cap (Jan-05-2024)
    1.281 Billion USD
    World Rank (Jul-30-2023)
    8,471
    Market Cap (Jul-30-2023)
    1.056 Billion USD
    World Rank (Dec-25-2022)
    7,863
    Market Cap (Dec-25-2022)
    1.116 Billion USD
    World Rank (Jan-07-2022)
    13,040
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    134 Million USD
    Annual Operating Income in USD
    -182 Million USD
    Annual Net Income in USD
    -178 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Deciphera Pharmaceuticals is a Healthcare company. The company developing novel drug candidates to improve the lives of cancer patients by addressing key mechanisms of tumor and drug resistance that limit the effectiveness of many cancer therapies. The headquarters is in USA.
  8. Akero Therapeutics

    World Rank (Jan-05-2024)
    7,478
    Market Cap (Jan-05-2024)
    1.272 Billion USD
    World Rank (Jul-30-2023)
    5,174
    Market Cap (Jul-30-2023)
    2.349 Billion USD
    World Rank (Dec-25-2022)
    4,983
    Market Cap (Dec-25-2022)
    2.284 Billion USD
    World Rank (Jan-07-2022)
    11,418
    Market Cap (Jan-07-2022)
    0.70 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -115 Million USD
    Annual Net Income in USD
    -112 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Akero Therapeutics is a Biotechnology company focused on reverse the course of serious metabolic diseases and transform patients. The headquarters is in USA.
  9. Peptidream

    World Rank (Jan-05-2024)
    7,512
    Market Cap (Jan-05-2024)
    1.258 Billion USD
    World Rank (Jul-30-2023)
    6,400
    Market Cap (Jul-30-2023)
    1.676 Billion USD
    World Rank (Dec-25-2022)
    6,147
    Market Cap (Dec-25-2022)
    1.649 Billion USD
    World Rank (Jan-07-2022)
    5,361
    Market Cap (Jan-07-2022)
    2.59 Billion USD
    Annual Revenue in USD
    68 Million USD
    Annual Net Income in USD
    26 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    PeptiDream is a Biopharmaceutical company. It is the platform which enables the production of highly diverse non standard peptide libraries with high efficiency for the identification of highly potent and selective hit candidates which then can be developed into peptide based, small molecule based or peptide drug conjugate based therapeutics. The headquarters is in Japan.

Share

Ads